Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 12:46 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 625–648 of 1,410 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiovascular Function Clear all

Conditions: Single Ventricle Heart Disease After Fontan Surgery
Interventions: Cardiac catheterization; Diagnostic Test
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 3 Years to 40 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Functional Mitral Regurgitation, Mitral Regurgitation, Mitral Insufficiency
Interventions: Edwards Cardioband System, Guideline Directed Medical Therapy; Device · Drug
Lead sponsor: Edwards Lifesciences; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 24
States / cities: Los Angeles, California • Palo Alto, California • Aurora, Colorado + 18 more

Conditions: Pulmonary Hypertension
Interventions: 11C-acetate, [18F]Fluoro-2-deoxy-2-D-glucose, Cardiac MRI; Drug · Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 80 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cerebrovascular Disorders, Healthy, Nervous System Diseases, Spinal Cord Injuries
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 175 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1986 – 2001
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Heart Failure
Interventions: Heart Failure; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 146 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2024
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Stroke
Interventions: Nutritional Supplementation; Drug
Lead sponsor: Burke Rehabilitation Hospital; Other
Eligibility: 18 Years to 95 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 1
States / cities: White Plains, New York

Conditions: Atherosclerosis
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 83 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Stroke, Physical Disability
Interventions: peripheral vibration stimulation, therapy; Other · Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Congenital Heart Disease, Single-ventricle
Interventions: Transthoracic Echocardiogram or Cardiac MRI, Ventripoint Echocardiogram; Device
Lead sponsor: Duke University; Other
Eligibility: Not listed
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Athletes, Atrial Fibrillation, Catheter Ablation
Interventions: Pulmonary Vein Isolation; Procedure
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Hypertension
Interventions: Aerobic Exercise, Relaxation; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 45 Years to 65 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Stroke
Interventions: task-practice therapy, Vibration; Behavioral · Other
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Peripheral Arterial Disease
Interventions: Exercise, Weight Loss; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 55 Years to 90 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Peripheral Arterial Disease
Interventions: Yoga intervention; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 41 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Physiological Responses to High-Intensity Exercise
Interventions: Q-Collar™; Device
Lead sponsor: University of Northern Iowa; Other
Eligibility: 18 Years to 35 Years · Male only
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Cedar Falls, Iowa

Conditions: Hypertrophic Cardiomyopathy
Interventions: Pirfenidone; Drug
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: Not listed
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2003
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Congenital Heart Defects
Interventions: Not listed
Lead sponsor: Emory University; Other
Eligibility: Up to 21 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Heart Failure
Interventions: cardiac MRI; Device
Lead sponsor: Marie Csete MD, PhD; Other
Eligibility: 18 Years to 90 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 2
States / cities: Pasadena, California

Conditions: Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline, Family History of Dementia
Interventions: Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine), PCP; Drug · Other
Lead sponsor: Rong Zhang; Other
Eligibility: 60 Years to 85 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Hypertension
Interventions: Nebivolol, Metoprolol; Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Premature Endothelial Dysfunction, Rheumatoid Arthritis, Healthy
Interventions: Not listed
Lead sponsor: Orrin M Troum, M.D. and Medical Associates; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Heart Failure, Congestive
Interventions: Intramyocardial injection of bone marrow mononuclear cells, Intramyocardial injection of CD34+ selected bone marrow mononuclear cells, LVAD alone; Biological · Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 7
States / cities: Oak Lawn, Illinois • Louisville, Kentucky • New York, New York + 3 more

Conditions: Stroke
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 80 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cardiovascular Disease
Interventions: N-acetylcysteine, Placebo; Drug
Lead sponsor: Boston University; Other
Eligibility: 21 Years to 65 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Study of Effects of Sildenafil on Patients With Fontan Heart Circulation

Edwards Cardioband System ACTIVE Pivotal Clinical Trial (ACTIVE)

11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension

Non-Invasive Electrical Stimulation of the Human Brain

The Determination of Important Mechanical Patterns of Left Ventricular Efficiency-MV02 Study

Study Impact of Nutritional Supplementary Treatment of Undernourished Stroke Patient on Functional Outcome Measures

Effects of EGCG-Enhanced Extra Virgin Olive Oil on Endothelial Function

Neuroplasticity With Daily Use of a Sensorimotor Priming Vibration System to Improve Hand Function After Stroke

Ventripoint Single Ventricle Study

Pulmonary Vein Isolation in Athletes

Physical Fitness, Cardiovascular and Brain Health

Functional Connectivity & Stimulation-enhanced Therapy Post Stroke

Exercise and Weight Loss in PAD

Yoga to Improve Physical Function and Maximal Walking Distance Among Patients With Peripheral Arterial Disease

Effects of the Q-Collar During High-Intensity Cycling Exercise

Pirfenidone to Treat Hypertrophic Cardiomyopathy

Using Tissue Doppler/Synchronization to Determine Heart Function in Children With Congenital Heart Disease

Establishing a Non-invasive Method to Measure Your Heart's Performance

Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)

Nebivolol Effect on Nitric Oxide Levels, Blood Pressure, and Renal Function in Kidney Transplant Patients

Exploratory Trial to Evaluate Premature Endothelial Dysfunction in Early Rheumatoid Arthritis(RA)Compared to Patients With Established RA, and Normal Subjects

Bone Marrow Cell Transplantation to Improve Heart Function in Individuals With End-Stage Heart Failure

Motor Performance in Chronic Stroke Patients

ROS Signaling in Endothelial Function